http://goo.gl/MTJqUM
Preliminary results of an open-label trial carried in the journal of Headache and Pain reported that a single treatment with electroCore's hand held non-invasive vagus nerve stimulation (nVNS) device gammaCore, completely resolved 44.8% of migraines within 30 minutes, with an additional 11.4% experiencing moderate benefits (incomplete resolution of their headaches) by 2 hours. This result follows two presentations at the International headache meeting in Copenhagen (EHMTIC) in September showing that patients using gammaCore plus standard of care achieved a 43.4% reduction in the number of weekly cluster headacheattacks compared with 12.5% (p=0.002) in patients treated with the best available standard of care. It also found that patients experienced a greater reduction in number of attacks the longer they stayed on treatment.